1.
Acta Gastroenterol Belg
; 84(4): 663-665, 2021.
Artículo
en Inglés
| MEDLINE
| ID: mdl-34965049
RESUMEN
Plasmablastic lymphoma (PBL) represents a rare and aggressive subtype of diffuse large B cells lymphoma (DLBCL) most associated with the human immunodeficiency virus (HIV). Prognosis remains poor despite various treatment approaches. We describe an evolution at six months of HIV negative PBL and Ebstein Barr virus (EBV) positive PBL with chemotherapy. Role of radiotherapy is still unclear.